Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
29.08. | Insplorion AB: Quarterly report Q2 2025 | 1.033 | GlobeNewswire (Europe) | April - June
Outcome April - JuneNet sales amounted to 51 (160) KsekProfit after financial items amounted to -5 215 (-5 376) kSEKEarnings per share before and after dilution: SEK -0,09 (-0,23)Cash flow... ► Artikel lesen | |
04.08. | Insplorion AB: Update on Insplorion's strategic development and ongoing key initiatives | 411 | GlobeNewswire (Europe) | We are pleased to share a summary of recent developments at Insplorion. The update includes: (i) progress in our strategic collaboration with Consilium Safety Group, including a follow-up order valued... ► Artikel lesen | |
INSPLORION Aktie jetzt für 0€ handeln | |||||
07.05. | Insplorion AB: Bulletin from Insplorion AB's Annual General Meeting 2025 | 853 | GlobeNewswire (Europe) | Today Insplorion AB held its Annual General Meeting. The AGM resolved on all points in accordance with the Board's and the Nomination Committee's proposals
The meeting approved the results and balance... ► Artikel lesen | |
05.05. | Insplorion AB: Insplorion officially launches the Insplorion NPS-P2 hydrogen detector | 773 | GlobeNewswire (Europe) | Insplorion, an innovative hydrogen sensor company, is proud to announce the official launch of the Insplorion NPS-P2 hydrogen detector.
The Insplorion NPS-P2 has been developed to detect hydrogen quickly... ► Artikel lesen | |
24.04. | Insplorion AB: Quarterly report Q1 2025 | 763 | GlobeNewswire (Europe) | January - March
Outcome January - MarchNet sales amounted to 604 (951) kSEKProfit after financial items amounted to -4,238 (-4,158) kSEKEarnings per share before and after dilution: SEK -0.09 (-0.20)... ► Artikel lesen | |
20.02. | Insplorion AB: Year-end report 2024 | 880 | GlobeNewswire (Europe) | October - December
Outcome October - December• Net sales amounted to 264 (258) kSEK• Profit after financial items amounted to -6,671 (-8,694) kSEK• Earnings per share before and after dilution: SEK... ► Artikel lesen | |
22.11.24 | Insplorion AB: Quarterly Report Q3 2024 | 1.067 | GlobeNewswire (Europe) | July - September
Outcome July - SeptemberNet sales amounted to TSEK 490 (1 491)Profit after net financial items amounted to TSEK -3 459 (-2 745)Basic and diluted earnings per share: SEK -0.15 (-0.21)... ► Artikel lesen | |
12.11.24 | Nasdaq Stockholm AB: New last trading day for paid subscription units (BTU) of Insplorion AB | 974 | GlobeNewswire | At the request of Insplorion AB, the last trading day in Insplorion AB's paid
subscription units will be changed from 2024-11-13 to 2024-11-18.
Instrument: Paid subscription units
Short... ► Artikel lesen | |
07.10.24 | Nasdaq Stockholm AB: Listing of unit rights and paid subscription units of Insplorion AB | 1.015 | GlobeNewswire | With effect from October 08, 2024, the unit rights in Insplorion AB will be
traded on First North Growth Market. Trading will continue up until and
including October 17, 2024.
Instrument: Unit rights... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
FORMYCON | 25,350 | 0,00 % | Formycon-Aktie mit leichten Kursgewinnen (22,75 €) | Am deutschen Aktienmarkt liegt der Anteilsschein von Formycon zur Stunde im Plus. Die Aktie notiert derzeit bei 22,75 Euro. Ein Plus in Höhe von 65 Cent erfreut derzeit die Aktionäre von Formycon. Das... ► Artikel lesen | |
ONTO INNOVATION | 125,00 | +0,81 % | Jefferies stuft Onto Innovation auf "Buy" hoch: Erholung im CoWoS-Markt als Kurstreiber | ||
VEECO INSTRUMENTS | 27,400 | +1,48 % | Axcelis Technologies, Inc.: Axcelis Technologies and Veeco Instruments to Combine, Creating a Leading Semiconductor Equipment Company | Diversifies Portfolio with Complementary Capital Equipment Solutions and Expands Addressable Markets Supported by Secular Tailwinds Greater R&D Scale to Fuel Differentiated, Next-Generation... ► Artikel lesen | |
KOPIN | 2,356 | +2,52 % | KOPIN CORP - 8-K, Current Report | ||
GAUZY | 6,340 | +5,67 % | Gauzy Ltd. Announces Second Quarter 2025 Results | Record Backlog Purchase Orders of $42.9 Million at Quarter End Highly Anticipated New Product Lines Announced; Includes Commercial Aircraft Cabin Shading, ADAS Smart Vision for Buses, and Pre-Fabricated... ► Artikel lesen | |
SOLESENCE | 4,180 | -4,13 % | Solésence, Inc.: Solésence Reports Second Quarter 2025 Financial Results | ROMEOVILLE, Ill., July 31, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced... ► Artikel lesen | |
DOTZ NANO | 0,050 | +5,26 % | DOTZ NANO LIMITED: Dotz Announces First Commercial Order for DAC Sorbent | ||
LAMPETIA | 0,102 | 0,00 % | EQS-News: Lampetia AG: Halbjahresfinanzbericht auf neuer Webseite | EQS-News: Lampetia AG
/ Schlagwort(e): Halbjahresbericht
LAMPETIA AG: Halbjahresfinanzbericht auf neuer Webseite
30.09.2025 / 19:51 CET/CEST
Für den Inhalt der Mitteilung... ► Artikel lesen | |
NVE | 57,50 | -1,71 % | Dividendenbekanntmachungen (04.08.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AMERIPRISE FINANCIAL INC US03076C1062 1,6 USD 1,3806 EUR AMERISERV FINANCIAL INC US03074A1025 0,03 USD 0,0258 EUR ATLANTIC UNION... ► Artikel lesen | |
OBDUCAT | 0,022 | -4,35 % | NGM MARKET NOTICE: #25-43 Information regarding the last day of trading in paid subscribed shares issued by Obducat AB | ||
ACACIA RESEARCH | 2,680 | -1,47 % | Acacia Research und Partner entwickeln eine mit Bitcoin gesicherte Gewerbedarlehensstrategie | ||
ADVANCE ZINCTEK | 0,510 | 0,00 % | ADVANCE ZINCTEK LIMITED: Improvement of 26.83% in First Quarter Revenue - FY26 | ||
NANOFOCUS | 1,780 | 0,00 % | Nanofocus: Abfindungsangebot klar über aktuellem Kurs | Seit Ende Mai ist bekannt, dass die Carl Mahr Holding Nanofocus übernehmen will. Jetzt wird die Sache sehr konkret. Die Gesellschaft aus Göttingen legt ein konkretisiertes Squeeze-Out-Verlangen vor.... ► Artikel lesen | |
RIBER | 3,285 | -0,45 % | Riber's first-half 2025 revenue and earnings impacted by deliveries being concentrated into second-half | ||
NANOVIRICIDES | 1,140 | -2,56 % | NanoViricides, Inc. Has Filed its Annual Report | Broad-spectrum Antiviral NV-387 At Phase II Clinical Trial Stage - NV-387 Could Become a Revolutionary Antiviral for Respiratory Viral Infections SHELTON, CONNECTICUT / ACCESS Newswire / September 30... ► Artikel lesen |